Peptides for Cognitive Function & Nootropic Goals

How peptide Targets Peptides for Cognitive Function

Semax and Selank, both Russian nootropic peptides, have substantial clinical literature in their native country but limited Western replication. Semax has published data in ischemic stroke recovery and cognitive impairment, where effect sizes are modest but consistent. Selank has anxiolytic data suggesting non-sedating anxiety relief comparable to low-dose benzodiazepines without dependence.

Both are administered intranasally (poor oral bioavailability). N-Acetyl Semax is a modified form with extended half-life. Western evidence is thin; most published trials are in Russian journals and have not been independently replicated.

For general cognitive enhancement in healthy adults, peptide evidence is weaker than for established nootropics like caffeine, creatine, or structured exercise. Peptide nootropics make more sense for specific indications (post-stroke, chronic anxiety) than for general 'smart drug' use.